Summary
3-Fluoro-PCP is a potent dissociative anesthetic structurally related to PCP and 3-MeO-PCP, characterized by stimulating dissociation with a steep dose-response curve. First detected in Slovenia in October 2020 and now controlled in multiple jurisdictions. Features sub-micromolar affinity for the PCP binding site with slightly reduced potency versus PCP but improved metabolic stability. User reports describe clear-headed but manic dissociation with distinctive cooling menthol-like body sensations rather than sedation. Higher doses produce pronounced amnesia, time loops, and delusional states.
Dose Information
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Oral | 19-60 min | 30-60 min | 1.0-3.0 hrs | 2.0-4.0 hrs | 4.0-8.0 hrs |
| Sublingual | 19-60 min | 30-60 min | 1.0-3.0 hrs | 2.0-4.0 hrs | 4.0-8.0 hrs |
| Insufflated | 4-10 min | 19-40 min | 1.0-3.0 hrs | 2.0-4.0 hrs | 4.0-8.0 hrs |
| Rectal | 10-30 min | 30-60 min | 1.0-3.0 hrs | 2.0-4.0 hrs | 4.0-8.0 hrs |
| Intramuscular | 1-4 min | 10-19 min | 1.0-3.0 hrs | 2.0-4.0 hrs | 4.0-8.0 hrs |
Tolerance
Build-up
develops with repeated use over days to weeks
Reset
2–4 weeks for noticeable reduction
Effects
Positive
- Physical euphoria
- Stimulation
- Pain relief
- Analgesia
Negative
- Numbness
- Loss of balance
- Nausea
- Spontaneous bodily sensations
- Physical disconnection
- Sedation
Positive
- Analysis enhancement
- Cognitive euphoria
- Conceptual thinking
Negative
- Cognitive disconnection
- Depersonalization
- Amnesia
- Motor control loss
- Derealization
- Memory suppression
- Time distortion
Positive
- Tactile enhancement
- Increased music appreciation
Negative
- Visual acuity suppression
- Disinhibition
- Derealization
- Tactile suppression
- Spatial disorientation
- Double vision
- Visual disconnection
- Auditory distortion